17 July 2023
Top hires for VC & PE portfolio companies Q2-2023
Search Highlights
Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.
This quarter’s successful placements include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Cell therapy | Switzerland |
| CEO | Contract research services | Australia |
| CEO | Vaccines | Switzerland |
| Chief Technology Officer | Medical information services | UK |
| Chief Scientific Officer | Small molecule biopharma | Denmark |
| Global Head of Marketing | Natural ingredients | Denmark |
| VP Cancer Biology | tRNA-based therapeutics | US |
| VP Regulatory & Quality Affairs | Ophthalmology technology | France |
| VP Business Development Oncology | Novel drug discovery | US |
| VP Corporate Development | Radiopharmaceuticals | Germany/ China |
| Country Chief Financial Officer | Veterinary services | Austria |
| Chair | AI/Machine learning for drug discovery | Eastern Europe |
| Board Director | Cell therapy | Switzerland |
| Partner | Life science investor | UK |
Newly opened projects include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Medtech | France |
| CEO | GPCR immunotherapies | US |
| Chief Business Officer | Precision biotherapeutics | Singapore |
| Chief Technology Officer | Foodtech | Belgium |
| Chief Medical Officer | siRNA technology | US |
| Chief Hospital Officer | EHR data platform | Spain |
| Chief Development Officer | Cancer immunotherapies | Germany |
| VP Generative AI | Drug discovery | UK |
| VP Clinical and Regulatory | Implantable devices | UK |
| VP Business Development | Contract research services | US |
| Head Pharma Clinical Development | Drug delivery | US |
| Board Director | T-cell therapies | Sweden |
| Board Director | Digitalised nutrition / wellness | Switzerland |
| Scientific Operating Partner | Science-focused VC | UK |